|
Market Closed -
Other stock markets
|
After hours 06:08:36 pm | |||
| 1,058.18 USD | +3.66% |
|
1,064.00 | +0.55% |
| Feb. 06 | Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market | RE |
| Feb. 06 | Biogen forecasts upbeat annual profit, eyes 2028 launch of key drugs | RE |
EPS & Dividend: Eli Lilly and Company
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | 2.96 | 3.4 | 3.92 | 4.52 | 5.2 | 6 | 6.593 | 7.364 |
| Rate of return | 1.75% | 1.23% | 1.07% | 0.78% | 0.67% | 0.56% | 0.65% | 0.72% |
| EPS 2 | 6.79 | 6.12 | 6.9 | 5.8 | 11.71 | 22.95 | 33.34 | 40.14 |
| Distribution rate | 43.6% | 55.6% | 56.8% | 77.9% | 44.4% | 26.1% | 19.8% | 18.3% |
| Reference price 2 | 168.84 | 276.22 | 365.84 | 582.92 | 772.00 | 1,020.84 | 1,020.84 | 1,020.84 |
| Nbr of stocks (in thousands) | 906,582 | 906,592 | 950,178 | 899,307 | 900,432 | 895,381 | 895,381 | - |
| Announcement Date | 1/29/21 | 2/3/22 | 2/2/23 | 2/6/24 | 2/6/25 | 2/4/26 | - | - |
Past dividends: Eli Lilly and Company
| 2025-11-13 | Quarterly 1.5 USD |
| 2025-08-14 | Quarterly 1.5 USD |
| 2025-05-15 | Quarterly 1.5 USD |
| 2025-02-13 | Quarterly 1.5 USD |
| 2024-11-14 | Quarterly 1.3 USD |
| 2024-08-14 | Quarterly 1.3 USD |
| 2024-05-14 | Quarterly 1.3 USD |
| 2024-02-13 | Quarterly 1.3 USD |
| 2023-11-13 | Quarterly 1.13 USD |
| 2023-08-13 | Quarterly 1.13 USD |
| 2023-05-11 | Quarterly 1.13 USD |
| 2023-02-13 | Quarterly 1.13 USD |
| 2022-11-13 | Quarterly 0.98 USD |
| 2022-08-11 | Quarterly 0.98 USD |
| 2022-05-12 | Quarterly 0.98 USD |
| 2022-02-13 | Quarterly 0.98 USD |
| 2021-11-11 | Quarterly 0.85 USD |
| 2021-08-11 | Quarterly 0.85 USD |
| 2021-05-12 | Quarterly 0.85 USD |
| 2021-02-10 | Quarterly 0.85 USD |
Upcoming events: Eli Lilly and Company
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | 0.57% | 0.65% | 45.27x | 34.18x | 14.74x | |
| 2.17% | 2.23% | 22.99x | 7.31x | 6.37x | |
| 2.98% | 3.14% | 61.16x | 20978.93x | 7.28x | |
| 2.8% | 2.88% | 18.9x | 6.63x | 4.65x | |
| 2.7% | 2.81% | 15.46x | 5.4x | 4.96x | |
| 1.72% | 1.81% | 29.54x | 6.54x | 5.39x | |
| 2.98% | 2.93% | 20.12x | 6.31x | 5.71x | |
| 3.85% | 4.12% | 13.22x | 5.71x | 4.56x | |
| 2.6% | 2.73% | 28.58x | 21.89x | 6.68x | |
| 6.45% | 6.65% | 12.92x | 1.66x | 3.14x | |
| Average | 2.88% | 2.99% | 26.82x | 2,107.46x | 6.35x | |
| Weighted average by Cap. | 2.28% | 2.37% | 31.20x | 2,225.53x | 7.92x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
